{"id":"clostridium-butyricum-capsule","safety":{"commonSideEffects":[{"rate":null,"effect":"Abdominal discomfort"},{"rate":null,"effect":"Flatulence"},{"rate":null,"effect":"Diarrhea"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"C. butyricum is a gram-positive, anaerobic bacterium that ferments carbohydrates to produce butyrate, which serves as an energy source for colonocytes and strengthens the intestinal epithelial barrier. Butyrate also promotes the differentiation of regulatory T cells and reduces pro-inflammatory cytokine production, thereby restoring dysbiotic microbiota balance and reducing intestinal inflammation.","oneSentence":"Clostridium butyricum is a live biotherapeutic that colonizes the gut and produces butyrate, a short-chain fatty acid that supports intestinal barrier function and modulates immune homeostasis.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:19:10.497Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Diarrhea-predominant irritable bowel syndrome"},{"name":"Antibiotic-associated diarrhea"},{"name":"Inflammatory bowel disease"}]},"trialDetails":[{"nctId":"NCT07263880","phase":"PHASE1, PHASE2","title":"Clostridium Butyricum in Stenosing Crohn's Desease","status":"NOT_YET_RECRUITING","sponsor":"San Giovanni Addolorata Hospital","startDate":"2025-12-01","conditions":"Crohn Disease (CD)","enrollment":40},{"nctId":"NCT07167342","phase":"PHASE4","title":"The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2025-10-31","conditions":"Colorectal Adenoma, Probiotics","enrollment":300},{"nctId":"NCT07152886","phase":"PHASE4","title":"The Effects of Clostridium Butyricum on Adverse Events During Adjuvant Chemotherapy for Colorectal Cancer","status":"NOT_YET_RECRUITING","sponsor":"The Affiliated Hospital of Qingdao University","startDate":"2025-10-31","conditions":"Colorectal Cancer, Chemotherapeutic Toxicity","enrollment":238},{"nctId":"NCT06794723","phase":"PHASE2","title":"A Probiotic Based Intervention in Pregnancies Complicated by GDM","status":"NOT_YET_RECRUITING","sponsor":"Queen's University","startDate":"2025-10-01","conditions":"Gestational Diabetes Mellitus (GDM), Microbiome, Human","enrollment":173},{"nctId":"NCT06992154","phase":"EARLY_PHASE1","title":"Role of Akkermansia Muciniphila in Acne Vulgaris","status":"NOT_YET_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-03","conditions":"Acne","enrollment":34},{"nctId":"NCT05348694","phase":"PHASE4","title":"OsteoPreP: Food Supplements for Postmenopausal Bone Health","status":"UNKNOWN","sponsor":"Australian Catholic University","startDate":"2022-05-01","conditions":"Postmenopausal Osteopenia, Bone Loss, Age Related, Age-Related Sarcopenia","enrollment":160},{"nctId":"NCT06399419","phase":"PHASE1","title":"CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney Cancer","status":"RECRUITING","sponsor":"Osel, Inc.","startDate":"2024-06-19","conditions":"Advanced Clear Cell Renal Cell Carcinoma, Advanced Renal Cell Carcinoma, Advanced Sarcomatoid Renal Cell Carcinoma","enrollment":28},{"nctId":"NCT06213480","phase":"NA","title":"Next-Generation Synbiotic in Individuals With Overweight or Obesity","status":"UNKNOWN","sponsor":"Texas Christian University","startDate":"2024-01-10","conditions":"Overweight and Obesity","enrollment":60},{"nctId":"NCT05762887","phase":"NA","title":"Clinical Evaluation of the Antidepressant Effect of the Use of Probiotics in Bipolar Disorder","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2023-01-09","conditions":"Bipolar Disorder","enrollment":84},{"nctId":"NCT05687409","phase":"PHASE4","title":"Synbiotics Interventions for Managing Cirrhosis and Its Complications","status":"COMPLETED","sponsor":"First Affiliated Hospital of Zhejiang University","startDate":"2019-11-24","conditions":"Cirrhosis, Liver, Metagonimiasis","enrollment":120},{"nctId":"NCT05237115","phase":"PHASE4","title":"Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy","status":"COMPLETED","sponsor":"Xijing Hospital of Digestive Diseases","startDate":"2020-05-05","conditions":"Gastritis, Peptic Ulcer, Dyspepsia","enrollment":600},{"nctId":"NCT02771470","phase":"PHASE1","title":"Intestinal Microflora in Lung Cancer After Chemotherapy","status":"COMPLETED","sponsor":"Shandong University","startDate":"2014-09","conditions":"Lung Cancer, Effects of Chemotherapy, Tumor Immunity","enrollment":41},{"nctId":"NCT02169388","phase":"PHASE1","title":"Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy","status":"UNKNOWN","sponsor":"Shandong University","startDate":"2014-06","conditions":"Gastrointestinal Neoplasms, Colorectal Cancer, Effects of Chemotherapy","enrollment":30},{"nctId":"NCT00947336","phase":"PHASE3","title":"Evaluation of Safety & Efficacy of Synbiotic on the Incidence and Recurrence of Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics","status":"COMPLETED","sponsor":"Govind Ballabh Pant Hospital","startDate":"2005-04","conditions":"Cirrhosis With Ascites","enrollment":110}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Clostridium butyricum capsule","genericName":"Clostridium butyricum capsule","companyName":"Xijing Hospital of Digestive Diseases","companyId":"xijing-hospital-of-digestive-diseases","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Clostridium butyricum is a live biotherapeutic that colonizes the gut and produces butyrate, a short-chain fatty acid that supports intestinal barrier function and modulates immune homeostasis. Used for Diarrhea-predominant irritable bowel syndrome, Antibiotic-associated diarrhea, Inflammatory bowel disease.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}